These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 21420472)

  • 1. Serotonergic neurotransmission in the ventral hippocampus is enhanced by corticosterone and altered by chronic amphetamine treatment.
    Barr JL; Forster GL
    Neuroscience; 2011 May; 182():105-14. PubMed ID: 21420472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonergic responses to stress are enhanced in the central amygdala and inhibited in the ventral hippocampus during amphetamine withdrawal.
    Li H; Scholl JL; Tu W; Hassell JE; Watt MJ; Forster GL; Renner KJ
    Eur J Neurosci; 2014 Dec; 40(11):3684-92. PubMed ID: 25234335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amphetamine withdrawal differentially affects hippocampal and peripheral corticosterone levels in response to stress.
    Bray B; Scholl JL; Tu W; Watt MJ; Renner KJ; Forster GL
    Brain Res; 2016 Aug; 1644():278-87. PubMed ID: 27208490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic administration of glucocorticoid receptor ligands increases anxiety-like behavior and selectively increase serotonin transporters in the ventral hippocampus.
    Scholl JL; Solanki RR; Watt MJ; Renner KJ; Forster GL
    Brain Res; 2023 Feb; 1800():148189. PubMed ID: 36462646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corticosterone in the ventral hippocampus differentially alters accumbal dopamine output in drug-naïve and amphetamine-withdrawn rats.
    Bray B; Clement KA; Bachmeier D; Weber MA; Forster GL
    Neuropharmacology; 2020 Mar; 165():107924. PubMed ID: 31881169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin in the ventral hippocampus modulates anxiety-like behavior during amphetamine withdrawal.
    Tu W; Cook A; Scholl JL; Mears M; Watt MJ; Renner KJ; Forster GL
    Neuroscience; 2014 Dec; 281():35-43. PubMed ID: 25241066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of chronic amphetamine treatment and acute withdrawal on serotonin synthesis and clearance mechanisms in the rat ventral hippocampus.
    Barr JL; Scholl JL; Solanki RR; Watt MJ; Lowry CA; Renner KJ; Forster GL
    Eur J Neurosci; 2013 Feb; 37(3):479-90. PubMed ID: 23157166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour necrosis factor-alpha and interleukin-2 differentially affect hippocampal serotonergic neurotransmission, behavioural activity, body temperature and hypothalamic-pituitary-adrenocortical axis activity in the rat.
    Pauli S; Linthorst AC; Reul JM
    Eur J Neurosci; 1998 Mar; 10(3):868-78. PubMed ID: 9753154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of bacterial endotoxin and interleukin-1 beta on hippocampal serotonergic neurotransmission, behavioral activity, and free corticosterone levels: an in vivo microdialysis study.
    Linthorst AC; Flachskamm C; Müller-Preuss P; Holsboer F; Reul JM
    J Neurosci; 1995 Apr; 15(4):2920-34. PubMed ID: 7536823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonin 2 receptor modulation of hyperthermia, corticosterone, and hippocampal serotonin depletions following serial exposure to chronic stress and methamphetamine.
    Doyle JR; Yamamoto BK
    Psychoneuroendocrinology; 2010 May; 35(4):629-33. PubMed ID: 19879056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic amphetamine treatment enhances corticotropin-releasing factor-induced serotonin release in the amygdala.
    Scholl JL; Vuong SM; Forster GL
    Eur J Pharmacol; 2010 Oct; 644(1-3):80-7. PubMed ID: 20655906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corticosterone and serotonergic neurotransmission in the hippocampus: functional implications of central corticosteroid receptor diversity.
    Meijer OC; de Kloet ER
    Crit Rev Neurobiol; 1998; 12(1-2):1-20. PubMed ID: 9444479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonergic lesions of the dorsal hippocampus differentially modulate locomotor hyperactivity induced by drugs of abuse in rats: implications for schizophrenia.
    Adams W; Ayton S; van den Buuse M
    Psychopharmacology (Berl); 2009 Nov; 206(4):665-76. PubMed ID: 19629448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Individual differences in amphetamine sensitization, behavior and central monoamines.
    Scholl JL; Feng N; Watt MJ; Renner KJ; Forster GL
    Physiol Behav; 2009 Mar; 96(3):493-504. PubMed ID: 19103211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stress- and antidepressant treatment-induced modifications of 5-HT₇ receptor functions in the rat brain.
    Tokarski K; Bobula B; Grzegorzewska-Hiczwa M; Kusek M; Hess G
    Pharmacol Rep; 2012; 64(6):1305-15. PubMed ID: 23406741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered serotonergic neurotransmission but normal hypothalamic-pituitary-adrenocortical axis activity in mice chronically treated with the corticotropin-releasing hormone receptor type 1 antagonist NBI 30775.
    Oshima A; Flachskamm C; Reul JM; Holsboer F; Linthorst AC
    Neuropsychopharmacology; 2003 Dec; 28(12):2148-59. PubMed ID: 12915860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonergic systems in the balance: CRHR1 and CRHR2 differentially control stress-induced serotonin synthesis.
    Donner NC; Siebler PH; Johnson DT; Villarreal MD; Mani S; Matti AJ; Lowry CA
    Psychoneuroendocrinology; 2016 Jan; 63():178-90. PubMed ID: 26454419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional effects of chronic electroconvulsive shock on serotonergic 5-HT(1A) and 5-HT(1B) receptor activity in rat hippocampus and hypothalamus.
    Gur E; Dremencov E; Garcia F; Van de Kar LD; Lerer B; Newman ME
    Brain Res; 2002 Oct; 952(1):52-60. PubMed ID: 12363404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential modulation of synaptic plasticity and local circuit activity in the dentate gyrus and CA1 regions of the rat hippocampus by corticosterone.
    Sharvit A; Segal M; Kehat O; Stork O; Richter-Levin G
    Stress; 2015; 18(3):319-27. PubMed ID: 25815975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in serotonergic neurotransmission between rats displaying high or low anxiety/depression-like behaviour: effects of chronic paroxetine treatment.
    Keck ME; Sartori SB; Welt T; Müller MB; Ohl F; Holsboer F; Landgraf R; Singewald N
    J Neurochem; 2005 Mar; 92(5):1170-9. PubMed ID: 15715667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.